Suchergebnisse - "Farkouh, Raymond"

PubPharm (83)

1

Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine Among US Children with Underlying Medical Conditions

enthalten in: Infectious diseases and therapy | 2024

von Rozenbaum, M. | Chilson, E. | Farkouh, R. | +9

2

Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in US infants

enthalten in: Vaccine | 2024

von Rozenbaum, M. | Huang, L. | Perdrizet, J. | +9

3

Cost-effectiveness and impact on infections and associated antimicrobial resistance of 20-valent pneumococcal conjugate vaccine in US children previously immunized with PCV13

enthalten in: Journal of medical economics | 2024

von Rozenbaum, M. | Huang, L. | Cane, A. | +7

4

A Response to : Letter to the Editor Regarding 'Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age'

enthalten in: Infectious diseases and therapy | 2023

von Rozenbaum, M. | Perdrizet, J. | Li, X. | +4

5

A Response to: Letter to the Editor Regarding ‘Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age’

enthalten in: Infectious diseases and therapy | 2022

von Rozenbaum, M. | Perdrizet, J. | Li, X. | +4

6

A Response to: Letter to the Editor Regarding ‘Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age’

enthalten in: Infectious diseases and therapy | 2022

von Rozenbaum, M. | Perdrizet, J. | Li, X. | +4

7

A Response to: Letter to the Editor Regarding ‘Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age’

enthalten in: Infectious diseases and therapy | 2022

von Rozenbaum, M. | Perdrizet, J. | Li, X. | +4

8

Burden of pneumococcal disease due to serotypes covered by the 13-valent and new higher-valent pneumococcal conjugate vaccines in the United States

enthalten in: Vaccine | 2022

von Huang, L. | Wasserman, M. | Grant, L. | +6

9

The broader impacts of otitis media and sequelae for informing economic evaluations of pneumococcal conjugate vaccines

enthalten in: Expert review of vaccines | 2022

von Perdrizet, J. | Farkouh, R. | Horn, E. | +3

10

Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in Current and Investigational Pneumococcal Conjugate Vaccines in Children Under Five Years of Age

enthalten in: Infectious diseases and therapy | 2021

von Wasserman, M. | Perdrizet, J. | Grant, L. | +5

1
2
3
4
5
6
7
8
9
Nächster »
[9]